Market Cap

InflaRx N.V. Market Capitalization:

$96.6 Million

USD as of July 1, 2024

business InflaRx N.V. Company Profile

InflaRx N.V. Main Stock Listing

NASDAQ: IFRX

Market Capitalization History of InflaRx N.V.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of InflaRx N.V. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $105.4 M -2.68%
Jan. 1, 2023 $108.3 M -30.25%
Jan. 1, 2022 $155.3 M -33.15%
Jan. 1, 2021 $232.3 M 65.33%
Jan. 1, 2020 $140.5 M -90.15%
Jan. 1, 2019 $1.43 B 36.91%
Jan. 1, 2018 $1.04 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

InflaRx N.V. Categories

Germany languages Healthcare languages Biotechnology
Germany Healthcare Germany Biotechnology

Stocks & Indices

InflaRx N.V. has the following listings and related stock indices.


Stock: NASDAQ: IFRX

Stock: FSX: IF0

Stock: XETR: IF0

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.